Insider Selling: Omega Healthcare Investors, Inc. (NYSE:OHI) COO Sells 56,725 Shares of Stock

Omega Healthcare Investors, Inc. (NYSE:OHI) COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Omega Healthcare Investors Stock Performance

NYSE:OHI traded down $0.32 during trading hours on Tuesday, reaching $40.39. The company had a trading volume of 1,280,184 shares, compared to its average volume of 1,687,011. The firm has a market cap of $9.98 billion, a price-to-earnings ratio of 36.65, a PEG ratio of 1.32 and a beta of 1.00. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19. The firm’s 50 day moving average price is $38.81 and its 200-day moving average price is $34.40. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $41.53.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The firm had revenue of $252.70 million during the quarter, compared to the consensus estimate of $205.92 million. During the same period in the previous year, the firm earned $0.74 EPS. The business’s revenue was up 17.5% on a year-over-year basis. On average, analysts forecast that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Monday, August 5th were paid a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 6.64%. The ex-dividend date was Monday, August 5th. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 241.44%.

Hedge Funds Weigh In On Omega Healthcare Investors

Institutional investors and hedge funds have recently made changes to their positions in the business. Hsbc Holdings PLC grew its holdings in Omega Healthcare Investors by 107.2% during the fourth quarter. Hsbc Holdings PLC now owns 249,374 shares of the real estate investment trust’s stock valued at $7,669,000 after purchasing an additional 129,009 shares during the period. Stifel Financial Corp grew its stake in shares of Omega Healthcare Investors by 1.0% during the 4th quarter. Stifel Financial Corp now owns 344,421 shares of the real estate investment trust’s stock valued at $10,560,000 after acquiring an additional 3,514 shares during the period. Treasurer of the State of North Carolina increased its holdings in Omega Healthcare Investors by 5.4% in the 4th quarter. Treasurer of the State of North Carolina now owns 111,844 shares of the real estate investment trust’s stock worth $3,429,000 after acquiring an additional 5,689 shares in the last quarter. Centersquare Investment Management LLC increased its holdings in Omega Healthcare Investors by 36.6% in the 4th quarter. Centersquare Investment Management LLC now owns 3,585,255 shares of the real estate investment trust’s stock worth $109,924,000 after acquiring an additional 960,997 shares in the last quarter. Finally, Cibc World Markets Corp purchased a new position in Omega Healthcare Investors during the fourth quarter valued at approximately $2,489,000. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Truist Financial raised their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Mizuho cut shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and lifted their target price for the stock from $34.00 to $35.00 in a report on Thursday, July 25th. Scotiabank raised their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research report on Monday, August 26th. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday. Eight investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $35.78.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.